Production (Stage)
GRI Bio, Inc.
GRI
$1.36
$0.064.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.92M | 4.47M | 4.32M | 4.57M | 8.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 0.00 | -250.00K | -250.00K |
| Total Operating Expenses | 9.39M | 8.24M | 8.31M | 8.37M | 12.04M |
| Operating Income | -9.39M | -8.24M | -8.31M | -8.37M | -12.04M |
| Income Before Tax | -13.23M | -12.07M | -8.26M | -8.28M | -12.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.23 | -12.07 | -8.26 | -8.28 | -12.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.23M | -12.07M | -8.26M | -8.28M | -12.77M |
| EBIT | -9.39M | -8.24M | -8.31M | -8.37M | -12.04M |
| EBITDA | -9.39M | -8.23M | -8.30M | -8.36M | -12.04M |
| EPS Basic | -108.64 | -203.94 | -315.16 | -422.82 | -458.34 |
| Normalized Basic EPS | -65.47 | -125.03 | -122.55 | -115.41 | -63.19 |
| EPS Diluted | -116.50 | -211.80 | -315.16 | -422.82 | -458.34 |
| Normalized Diluted EPS | -65.47 | -125.03 | -122.55 | -115.41 | -63.19 |
| Average Basic Shares Outstanding | 1.23M | 722.50K | 231.50K | 45.60K | 18.70K |
| Average Diluted Shares Outstanding | 1.23M | 722.50K | 249.60K | 81.80K | 73.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |